Jakubowitz Law Reminds Shattuck Shareholders of April 1, 2022 Lead Plaintiff Deadline
NEW YORK, April 1, 2022 /PRNewswire/ — Jakubowitz Law announces that a securities fraud class action lawsuit has been filed on behalf of shareholders of Shattuck LaboratoriesInc. (NASDAQ: STTK).
To receive updates on the trial, complete the form:
This lawsuit is on behalf of persons or entities who have purchased or otherwise acquired publicly traded securities of Shattuck: (1) pursuant to and/or the registration statement and related prospectus issued pursuant to Shattuck’s October 2020 initial public offering; and/or (2) between October 9, 2020 and November 9, 2021included.
Shareholders interested in acting as lead plaintiff representing the group of aggrieved shareholders have until April 1, 2022 seize the tribunal. Your ability to participate in any collection does not require you to serve as the lead plaintiff.
According to a complaint filed, Shattuck Laboratories, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the collaboration agreement with Takeda was not solid; (2) Takeda and Shattuck would “mutually agree” to terminate the collaboration agreement in essentially one year; (3) as a result, Shattuck would cease to receive any future milestone payments, royalties or other payments from Takeda; and (4) as a result, defendants’ statements regarding the Company’s business, operations and prospects were materially false and misleading and/or lacked reasonable basis at all relevant times.
The Jakubowitz Act is vigorous in pursuing justice for shareholders who have been victims of securities fraud. Lawyer advertisement. Prior results do not guarantee similar results.
1140 Avenue of the Americas
New York, New York 10036
Phone. : (212) 867-4490
Fax : (212) 537-5887
SOURCE Jakubowitz’s Law